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ABSTRACT The actin cytoskeleton is regulated by factors that influence polymer assembly, 
disassembly, and network rearrangement. Drugs that inhibit these events have been used to 
test the role of actin dynamics in a wide range of cellular processes. Previous methods of ar-
resting actin rearrangements take minutes to act and work well in some contexts, but can 
lead to significant actin reorganization in cells with rapid actin dynamics, such as neutrophils. 
In this paper, we report a pharmacological cocktail that not only arrests actin dynamics but 
also preserves the structure of the existing actin network in neutrophil-like HL-60 cells, human 
fibrosarcoma HT1080 cells, and mouse NIH 3T3 fibroblast cells. Our cocktail induces an arrest 
of actin dynamics that initiates within seconds and persists for longer than 10 min, during 
which time cells maintain their responsivity to external stimuli. With this cocktail, we demon-
strate that actin dynamics, and not simply morphological polarity or actin accumulation at the 
leading edge, are required for the spatial persistence of Rac activation in HL-60 cells. Our 
drug combination preserves the structure of the existing cytoskeleton while blocking actin 
assembly, disassembly, and rearrangement, and should prove useful for investigating the role 
of actin dynamics in a wide range of cellular signaling contexts.
INTRODUCTION
Actin dynamics are essential for many cellular processes, including 
the control of cell shape, movement, and division (Ridley et al., 
2003). To examine the role of actin dynamics in many cellular pro-
cesses, investigators commonly use pharmacological inhibitors 
that interfere with polymerization, depolymerization, and rear-
rangement of the actin cytoskeleton. These inhibitors can be 
sorted into several general classes. The first and most prevalent 
class of actin drugs includes those that interfere with actin polym-
erization. New actin polymerization can be inhibited by either se-
questering the free actin monomer pool with drugs like latrunculin 
(Spector et al., 1983; Coué et al., 1987) or by blocking the fast-
growing barbed ends of actin filaments with drugs like cytochala-
sin (Cooper, 1987; Figure 1A). A second class of actin drugs 
includes those that interfere with the disassembly of the actin net-
work. For example, jasplakinolide binds actin filaments and inter-
feres with disassembly (Cramer, 1999; Wilson et al., 2010; 
Figure 1A). Jasplakinolide also lowers the dissociation rate con-
stant for barbed-end actin to essentially zero, resulting in the in-
corporation of virtually all free actin at high jasplakinolide doses or 
long posttreatment times (Bubb et al., 2000; Kiuchi et al., 2011). A 
third class of actin inhibitors includes those that interfere with the 
rearrangement of the actin network. For example, the molecular 
motor myosin II is involved in restructuring the actin network from 
a geometry that favors protrusion to one that favors contraction 
(Verkhovsky et al., 1999). Myosin II also participates in the disas-
sembly of the actin network (Medeiros et al., 2006; Burnette et al., 
2008). Some drugs, such as blebbistatin (Straight et al., 2003), di-
rectly inhibit myosin II activity, whereas other compounds, such as 
the Rho kinase (ROCK) inhibitor Y27632 (Uehata et al., 1997), in-
hibit myosin II activators (Figure 1A).
Studies using single actin inhibitors have been successful in iden-
tifying cell processes that are dependent on the actin cytoskeleton. 
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lide preserve actin organization in melano-
phores (Semenova et al., 2008). Addition-
ally, blebbistatin slows actin dynamics in 
Aplysia bag cell neurons without grossly af-
fecting actin organization (Burnette et al., 
2008). We suspected (and later verified) that 
although previously published actin drugs 
and drug combinations can preserve actin 
organization in these slow-moving cells, 
they would fail to act fast enough to arrest 
actin dynamics in quickly moving cells, such 
as neutrophils. Chick fibroblasts and Aplysia 
bag cell neurons both move at ∼1 μm/min 
(Lin and Forscher, 1993; Cramer, 1999) com-
pared with 10 μm/min for neutrophils (Hau-
ert et al., 2002).
To investigate the role of actin dynamics 
in processes like cell polarity and directional 
sensing, we sought to identify a drug treat-
ment that quickly arrests actin dynamics by 
stopping polymerization, depolymerization, 
and reorganization. We wanted the drug 
treatment to preserve the existing actin or-
ganization in a range of cell types, including 
highly motile cells. In this paper, we report a 
new combination of actin inhibitors that is 
optimized to quickly freeze cell morphol-
ogy. We demonstrate that this cocktail, but 
none of the previously published combina-
tions of inhibitors, acts within seconds to 
block assembly, disassembly, and rearrange-
ment of the actin network. Using this drug 
combination, we demonstrate that actin dy-
namics, as opposed to morphological po-
larity or actin accumulation at the leading 
edge, are required for the spatial persis-
tence of Rac activation in HL-60 cells.
RESULTS
Our drug cocktail, unlike previously published combinations, 
rapidly arrests morphological changes in HL-60 cells
We sought to identify a combination of actin drugs that inhibits actin 
dynamics while preserving the structure of the existing cytoskeleton. 
Using neutrophil-like, differentiated HL-60 cells (Hauert et al., 2002), 
which exhibit rapid actin dynamics (Weiner et al., 1999), we evaluated 
several drugs and drug cocktails previously reported to inhibit actin 
dynamics in other cell types. We reasoned that any cocktail that in-
hibits actin dynamics while preserving the organization of the existing 
network should rapidly and persistently preserve cell morphology, as 
assayed by differential interference contrast (DIC) microscopy.
We first analyzed the ability of cytochalasin D to preserve cell 
morphology in migrating HL-60 cells. Cytochalasin D not only acts 
to inhibit actin polymerization by capping barbed ends but also sig-
nificantly slows disassembly of the actin network in structures such 
as Listeria actin tails (Kueh et al., 2008). In HL-60 cells, cytochalasin 
D treatment blocks leading-edge advancement but fails to inhibit 
significant morphological changes over a 5-min observation win-
dow. During this time period, both the leading edge and trailing 
edge retract, leading to a loss of morphological polarity (Figure 1B 
and Supplemental Movie S1).
Next we tested two different combinations of actin drugs re-
ported to slow actin rearrangements in other cells. A combination of 
For instance, the monomer-sequestering agent latrunculin has 
been used to show that actin polymerization and morphological 
rearrangements are not required for directional sensing in 
Dictyostelium discoideum and neutrophils (Parent et al., 1998; 
Servant et al., 2000). In contrast, filamentous actin is required for 
polarization of phosphatidylinositol 3,4,5-trisphosphate (PIP3) in 
response to uniform chemoattractant in neutrophils (Wang et al., 
2002).
Although actin inhibitors have been a successful tool in identify-
ing actin cytoskeletal-dependent processes, some of these single 
actin drugs not only block actin polymerization but may also signifi-
cantly perturb the existing organization of the actin network, poten-
tially complicating their interpretation. For example, latrunculin not 
only inhibits new assembly but also depolymerizes the existing actin 
cortex (Spector et al., 1983), which leads to a dramatic alteration in 
the mechanical properties of cells (Wakatsuki et al., 2001). Other 
single actin drugs have been shown to perturb the existing structure 
of the actin network (Cooper, 1987; Bubb et al., 1994; Uehata et al., 
1997; Straight et al., 2003). With careful optimization, some single 
actin drugs can stabilize actin dynamics without altering the overall 
organization of the actin network in some contexts. For instance, 
jasplakinolide is able to inhibit chick fibroblast lamellipodium protru-
sion without significant disruptions to the actin cytoskeleton (Cramer, 
1999), and low doses and short periods of treatment with jasplakino-
FIGURE 1: The JLY cocktail, but not previously published combinations of actin inhibitors, 
rapidly arrests cell morphology in HL-60 cells. (A) Schematic of actin inhibitors. Cytochalasin D 
caps the barbed end of actin filaments, thereby preventing further polymerization. 
Jasplakinolide binds to the side of actin filaments and inhibits polymer disassembly. Latrunculin 
B binds to actin monomers and prevents their incorporation into actin polymer. Blebbistatin 
directly inhibits the ATPase activity of myosin II, and the ROCK inhibitor Y27632 inhibits the 
signaling cascade that drives phosphorylation and activation of myosin II. (B–E) HL-60 cells were 
plated on fibronectin-coated slides and imaged with DIC microscopy. At t = −1 min, cells had 
been preincubated in (B–E) 100 nM fMLP and (C and D) 50 μM blebbistatin or (E) 10 μM Y27632 
for 10 min. At t = 0 min, (B) 10 μM cytochalasin D, (C) 500 nM latrunculin B, (D) 1 μM 
jasplakinolide, or (E) 8 μM jasplakinolide and 5 μM latrunculin B were added. Overlays represent 
successive cell outlines with black = 0 min, purple = 1 min, blue = 2 min, green = 3 min, orange 
= 4 min, red = 5 min. Scale bar: 10 μm. Images are representative of a minimum of five cells. 
(F) Cross-correlation of cell outline between t = 0 min and t = 5 min of cells in (B–E) indicates the 
ability of each drug or drug cocktail to stabilize cell morphology.
cytochalasin D
jasplakinolide
blebbistatin
Y27632
latrunculin B
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blebbistatin and latrunculin B has been reported to slow actin dy-
namics in primary murine dendritic cells (Renkawitz et al., 2009). Dif-
ferentiated HL-60 cells treated with this drug combination exhibit 
rapid retraction of the leading edge (Figure 1C and Movie S2). A 
combination of blebbistatin and jasplakinolide has also been re-
ported to slow actin dynamics in keratocytes (Wilson et al., 2010). 
However, this drug cocktail fails to rapidly arrest the advancement of 
the leading edge in HL-60 cells (Figure 1D and Movie S3).
We reasoned that the limitations of previously published cock-
tails stem from their inability to simultaneously inhibit actin depo-
lymerization, polymerization, and restructuring. To test this hypoth-
esis, we treated cells with a triple-drug cocktail containing 
jasplakinolide, latrunculin B, and Y27632, which are inhibitors of ac-
tin depolymerization, actin polymerization, and myosin II-based 
contractility, respectively. Cells treated with this triple-drug cocktail 
(which we refer to as JLY) exhibit a rapid freezing of cell morphology 
that initiates within seconds and persists for at least 10 min (Figure 
1E and Movie S4). Quantitative analysis of changes in cell outline 
confirmed that JLY maintains HL-60 cell morphology better than 
previously published methods (Figure 1F). Omission of any member 
of our three-drug JLY combination impaired the ability of this cock-
tail to rapidly preserve cell morphology in HL-60 cells (Supplemental 
Figure S1). With the exception of latrunculin, lower doses of each 
drug, alternative myosin inhibitors (such as blebbistatin and ML-7), 
and alternative drug combinations did not preserve cell morphol-
ogy as efficiently as our optimized concentrations of JLY (Figures S1 
and S2). JLY with a concentration of 2.5 μM latrunculin worked in a 
manner similar to optimized JLY.
JLY preserves steady-state actin organization
After determining that our triple-drug cocktail JLY effectively pre-
served cell morphology, we next tested the ability of JLY and other 
drug combinations to preserve the steady-state actin distribution in 
HL-60 cells. To visualize filamentous actin in living cells, we used an 
HL-60 cell line that stably expresses yellow fluorescent protein (YFP)-
actin (Van Keymeulen et al., 2006). We selected this probe over other 
actin-binding proteins, such as Lifeact (Riedl et al., 2008), because, 
unlike actin-binding proteins, YFP-actin incorporates into the actin 
network (Westphal et al., 1997) and is compatible with assays of 
long-term dynamics, such as photobleaching experiments (Lai et al., 
2008). We analyzed cells in oblique fluorescence illumination to de-
tect changes in filamentous actin concentration and organization and 
to reduce background from out-of-focus fluorescence. As expected, 
the drug combinations that failed to quickly arrest morphological 
changes, cytochalasin D, blebbistatin–latrunculin, blebbistatin–jas-
plakinolide (Figure 1, B–D), were unable to maintain the steady-state 
distribution of filamentous actin (Figure 2, A–C, and Movies S5–S7). 
In contrast, the JLY drug cocktail, which effectively preserves cell 
morphology (Figure 1E and Table S1), also maintains steady-state 
distribution of filamentous actin (Figure 2D and Movie S8).
JLY arrests actin dynamics in multiple cell types
We have demonstrated that the JLY triple-drug cocktail preserves 
steady-state actin polymer distribution in HL-60 cells. This could ei-
ther reflect an inhibition of actin polymerization and depolymeriza-
tion, or could represent significant but balanced rates of actin po-
lymerization and depolymerization with no net change in filament 
abundance. To discriminate between these possibilities, we assayed 
fluorescence recovery after photobleaching (FRAP) of YFP-actin. 
FRAP enables measurement of the rate of actin assembly by quanti-
fying YFP-actin recovery in the bleached region. Our photobleach-
ing setup takes 1–3 s to switch from photobleaching to fluorescence 
imaging. Because G-actin diffusion is rapid, this time is sufficient for 
the G-actin pool to equilibrate. As a result, we only assay fluores-
cence recovery of filamentous actin. JLY-treated cells exhibited only 
a 7% fluorescence recovery (n = 25) in the 10 min following photo-
bleaching (Figure 3, A and B, and Movie S9), suggesting a lack of 
significant new actin polymerization. The intensity of an unbleached 
FIGURE 2: JLY preserves steady-state actin organization in HL-60 cells. HL-60 cells stably expressing YFP-tagged actin 
were plated on fibronectin-coated slides and imaged in DIC and oblique fluorescence illumination. Cells were pretreated 
with 100 nM fMLP and (B and C) 50 μM blebbistatin or (D) 10 μM Y27632 for 10 min before imaging. At t = 0 min, 
(A) 10 μM cytochalasin D, (B) 500 nM latrunculin B, (C) 1 μM jasplakinolide, or (B) 8 μM jasplakinolide and 5 μM 
latrunculin B were added. Images are representative of a minimum of five cells. Scale bar: 10 μm.
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itors were not as effective at arresting actin dynamics (Figures S1, 
A–I, and S3). We conclude that our optimized combination of JLY 
effectively arrests actin polymerization, depolymerization, and actin 
reorganization in HL-60 cells.
We next evaluated the ability of JLY to block actin dynamics and 
morphological rearrangements in other mammalian cells, such as 
HT1080 human fibrosarcoma cells (Rasheed et al., 1974). HT1080 
cells were chosen because, like HL-60 cells, they are a model of 
mammalian cell chemotaxis (Mensing and Czarnetzki, 1984; 
VanCompernolle et al., 2003). Control HT1080 cells recovered to 
60% of their original intensity in approximately 1 min after photo-
bleaching (n = 5; Figure S4A), indicating rapid actin assembly. In 
contrast, the JLY-treated HT1080 cells exhibited only an 11% fluo-
rescence recovery (n = 20) in the 10 min after photobleaching 
(Figure 4, A and B, and Movie S10), suggesting an inhibition of actin 
polymerization. HT1080 cells exhibited only a 5% decrease (n = 20) 
in fluorescence signal of the non-bleached area of the actin network 
over 10 min (Figure 4B), suggesting minimal depolymerization. Fi-
nally, JLY also blocked actin rearrangements in HT1080 cells, as as-
sessed by the constant boundaries of the bleached region following 
drug treatment (Figure 4C).
In addition, we tested JLY in NIH 3T3 cells, a widely used cell line 
for studying mesenchymal cell migration (Ridley et al., 2003; 
Hakkinen et al., 2011). Control NIH 3T3 cells recovered to 22% of 
their original intensity in approximately 1 min after photobleaching 
(n = 13; Figure S4B), indicating rapid actin assembly. In contrast, JLY-
treated NIH 3T3 cells showed a 5% fluorescence recovery (n = 14) in 
the 10 min after photobleaching (Figure 4, D and E, and Movie S11). 
NIH 3T3 cells showed an 8% decrease (n = 14) in fluorescence signal 
in the unbleached area of the actin network over 10 min post–drug 
treatment (Figure 4E). Additionally, JLY also blocked actin rearrange-
ments in NIH 3T3 cells, as indicated by the consistent boundaries of 
the bleached region following drug treatment (Figure 4F). Together, 
these data suggest that JLY is effective at inhibiting actin polymer-
ization, depolymerization, and rearrangements in HT1080, NIH 3T3, 
and HL-60 cells and is likely to be broadly applicable to other mam-
malian cell lines.
JLY does not inhibit the ability of cells to respond to 
external stimuli
To test whether cells treated with JLY retain their ability to respond 
to external stimuli, we assayed calcium release of drug-treated HL-
60 cells following chemotactic stimulation. Calcium release was 
evaluated by loading HL-60 cells with the membrane-permeable 
calcium indicator Fluo-4-AM. Both control cells (n = 9) and JLY-
treated cells (n = 20) exhibited chemoattractant-dependent calcium 
release (Figure 5, A–C, and Movie S12), with a similar proportion of 
cells responding in both conditions. Calcium fluxes were noted in 
100% of control and 95% of JLY-treated cells following chemoat-
tractant stimulation with N-formyl-methionine-leucine-phenylala-
nine (fMLP). JLY treatment did not significantly alter either the basal 
calcium levels or the magnitude or kinetics of calcium release 
(Figure 5C). These data indicate that arresting actin dynamics with 
JLY does not prevent cell response to external stimuli.
To interpret results of experiments using JLY to study cell signal-
ing, it is important to know whether JLY competes with signaling 
proteins for binding to the actin network. Although jasplakinolide 
can interfere with some actin-binding molecules, such as phalloidin 
(Bubb et al., 1994), the doses of jasplakinolide used in JLY did not 
interfere with the actin-binding proteins Lifeact (Riedl et al., 2008) 
and Coronin3 (Spoerl et al., 2002) or the Arp2/3 complex (Mullins 
et al., 1998; Figure S5).
region of the cell was used to estimate the rate of actin depolymer-
ization after drug treatment. Cells showed only a 3% decrease in 
actin polymer signal over 10 min (n = 25; Figure 3B), indicating min-
imal actin depolymerization. Furthermore, we observed persistent 
boundaries of the bleached region in the 10 min following photo-
bleaching. The sharpness of this boundary suggests that there are 
minimal actin rearrangements following drug treatment (Figure 3C). 
Alternative combinations, concentrations, and timing of actin inhib-
FIGURE 3: JLY arrests actin depolymerization, polymerization, and 
myosin-based rearrangements. We used FRAP to analyze the ability of 
JLY to arrest actin depolymerization, polymerization, and 
rearrangements in YFP-actin expressing HL-60 cells. (A) Cells imaged 
in oblique fluorescence illumination were first pretreated with JLY, 
then photobleached in a rectangular region. Scale bar: 10 μm. 
(B) FRAP is a measure of actin assembly, and the fluorescence 
intensity of the nonbleached region estimates depolymerization. 
HL-60 cells display 7% recovery (blue box) in the 10 min after 
photobleaching (n = 25). HL-60 cells show 3% loss of filamentous 
actin signal over 10 min (n = 25), as evaluated by the loss of 
fluorescence intensity of the unbleached region of filamentous actin 
(red box). (C) The persistence of the bleached area can assay 
large-scale actin rearrangements. A line profile (green line) of the 
borders between unbleached and bleached regions indicates no 
detectable actin rearrangements in the 10 min after photobleaching 
for JLY-treated HL-60 cells. Error bars show SEM
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The role of the actin cytoskeleton in the spatial dynamics of Rac 
activation has not previously been investigated in HL-60 cells. Are 
actin rearrangements required to maintain polarity of Rac activity in 
uniform chemoattractant (actin plays this role for PIP3) or to termi-
nate Rac activation (actin plays this role for WAVE complex recy-
cling), or do actin rearrangements serve another role? Using popula-
tion assays, we previously showed that latrunculin treatment does 
not alter the magnitude of chemoattractant-induced Rac activation 
in HL-60 cells (Weiner et al., 2006). However, whether actin plays a 
role in the spatial organization of Rac activity in these cells is un-
known. We used total internal reflection fluorescence (TIRF) imaging 
of a fluorescently tagged Rac-GTP–binding domain, Pak-PBD-Ceru-
lean (Weiner et al., 2007), to follow the dynamics of Rac activation in 
living HL-60 cells. In control HL-60 cells stimulated with uniform 
chemoattractant, Pak-p21-binding domain (Pak-PBD) persistently 
accumulates at the leading edge (Figure 6, A and C, and Movie 
Actin dynamics are essential for the spatial persistence  
of Rac activity
We next examined the relationship between actin dynamics and the 
polarization of Rac activity, a key chemotactic signal in HL-60 cells. 
Actin inhibitors have previously been used to investigate how various 
chemotactic signals depend on actin dynamics in HL-60 cells. Some 
polarized responses are still observed in the absence of the actin cy-
toskeleton. For example, latrunculin B–treated HL-60 cells are able to 
polarize PIP3 in response to external gradients of chemoattractant 
(Servant et al., 2000). In contrast, latrunculin B–treated HL-60 cells 
lose their ability to polarize PIP3 in response to uniform chemoattrac-
tant stimulation (Wang et al., 2002). Moreover, latrunculin B–treated 
HL-60 cells are defective in their ability to recycle the actin nucleation–
promoting complex SCAR/WAVE (Suppressor of cyclical AMP Recep-
tor/Wiskott–Aldrich syndrome protein verprolin-homologous protein) 
from the membrane (Weiner et al., 2007; Millius et al., 2009).
FIGURE 4: JLY arrests actin dynamics in other mammalian cells. We used FRAP to analyze the ability of JLY to arrest 
actin depolymerization, polymerization, and rearrangements in YFP-actin expressing (A–C) HT1080 and (D–F) NIH 3T3 
cells. Cells imaged in oblique fluorescence illumination were first pretreated with JLY, then photobleached in a 
rectangular region. (B and E) FRAP is a measure of actin assembly, and the fluorescence intensity of the nonbleached 
region estimates depolymerization. (C and F) The persistence of the bleached area can assay large-scale actin 
rearrangements. (B) In HT1080 cells, 11% new actin polymerization (blue box) and 5% depolymerization (red box) 
occurred in the 10 min following JLY treatment (n = 20). (C) The line profile (green line) between unbleached and 
bleached regions indicates no detectable actin rearrangements in the 10 min after photobleaching for JLY-treated 
HT1080 cells. (E) NIH 3T3 cells display 8% recovery (blue box) in the 10 min after photobleaching (n = 14). NIH 3T3 cells 
show 5% loss of filamentous actin signal over 10 min (n = 14), as evaluated by the loss of fluorescence intensity of the 
unbleached region of filamentous actin (red box). (F) A line profile (green line) of the borders between unbleached and 
bleached regions indicates no detectable actin rearrangements in the 10 min after photobleaching for JLY-treated NIH 
3T3 cells. Error bars show SEM. Scale bar: 10 μm.
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control cells (Spector et al., 1983; Ayscough et al., 1997), leading to 
significantly altered mechanical properties of the cell (Wakatsuki 
et al., 2001).
To overcome these drawbacks and to more specifically test the 
role of actin dynamics in cellular function, we have developed a 
pharmacological cocktail that halts actin polymerization and depo-
lymerization, while also maintaining the organization of the existing 
actin network. In this study, we systematically analyze the ability of 
several combinations of actin drugs to preserve cell morphology 
and assay the dynamic organization of the actin cytoskeleton. We 
find that previously published drug combinations are unable to pre-
serve cell morphology and arrest actin dynamics in rapidly migrating 
HL-60 cells (Figures 1 and 2). We identify a drug combination that 
simultaneously inhibits actin disassembly, actin polymerization, and 
myosin II-based rearrangements through the concerted activities of 
jasplakinolide, latrunculin B, and Y27632, respectively (Figure 3). 
Our combination of drugs acts within seconds to preserve morpho-
logical changes and arrest actin dynamics in HL-60, HT1080, and 
NIH 3T3 cells (Figures 1, 3, and 4). This cocktail will enable research-
ers to analyze how cell function depends on actin dynamics without 
the complication of perturbing the existing organization of the actin 
network.
Actin dynamics are intimately involved in directed cell migration 
in amoeboid cells, such as neutrophils and Dictyostelium. The cel-
lular signals that drive morphological changes are normally tightly 
coupled to actin rearrangements in space and time. Several groups 
have used actin inhibitors to investigate how cell polarity relates to 
the actin cytoskeleton and morphological changes. Directional sens-
ing is not dependent on morphological changes: latrunculin-treated 
Dictyostelium and neutrophils maintain their ability to polarize sig-
nals such as PIP3 in response to external gradients of chemoattrac-
tant (Parent et al., 1998; Servant et al., 2000). However, several 
chemotactic signaling events depend on the actin cytoskeleton. 
Latrunculin-treated neutrophils lose their ability to generate PIP3 
asymmetry in uniform chemoattractant (Wang et al., 2002). Further-
more, actin polymerization is essential for the recycling of nucleation-
promoting factors such as the SCAR/WAVE2 complex in neutrophils 
(Weiner et al., 2007; Millius et al., 2009). In this study, we use JLY to 
show that actin dynamics are not essential for global Rac activation 
but are required for the spatial persistence of Rac activity at the mor-
phological leading edge during random migration (Figure 6).
The JLY cocktail is a useful tool for revisiting previous studies in 
the chemotactic signaling field and for refining our understanding of 
the complex feedback loops that underlie cell polarity. Cells that 
lack actin polymer can still polarize signals such as PIP3 in response 
to external gradients of chemoattractant (Parent et al., 1998; Servant 
et al., 2000). However, these cells show a number of qualitatively 
different behaviors compared with control cells. If latrunculin-treated 
Dictyostelium are exposed to a point source of chemoattractant and 
are challenged with a second input, they rapidly reorient polarity, if 
the second source is of significantly higher concentration (Devreotes 
and Janetopoulos, 2003), or establish two crescents of PIP3 accumu-
lation, if the second source is equal to the first input (Janetopoulos 
et al., 2004). In contrast, untreated Dictyostelium challenged with 
two point sources of chemoattractant maintain a single axis of PIP3 
accumulation and often preserve their existing leading edge (Dev-
reotes and Janetopoulos, 2003). These experiments suggest uniform 
sensitivity for unpolarized latrunculin-treated cells, whose internal 
signaling state mirrors the external chemoattractant gradient. In 
contrast, cells with a functional actin cytoskeleton exhibit localized 
sensitivity at the leading edge, possibly due to actin-based scaffold-
ing of polarity components at the cell front (Devreotes and 
FIGURE 5: Cells retain their responsivity to external signals following 
JLY treatment. JLY-treated HL-60 cells retain their ability to activate 
intracellular calcium release in response to chemoattractant. Both 
untreated cells (A, n = 9) and JLY-treated cells (B, n = 20), release 
calcium in response to stimulation with 100 nM fMLP, as assayed with 
the calcium indicator dye Fluo-4-AM. The proportion of cells that 
release calcium in response to chemoattractant is similar for control 
and JLY-treated cells (100 and 95%, respectively). Calibration bar 
indicates intensity (a.u.); scale bar: 20 μm. (C) A representative time 
course of calcium release following stimulation with 100 nM fMLP at 
t = 4 min in control and JLY-treated cells. Quantitative analysis was 
performed using a region of interest (ROI) that was chosen to be large 
enough to contain the cell in all time points. The average intensity was 
background-subtracted, and this corrected intensity value (average 
ROI intensity – background intensity) was plotted over time. Control 
cell time course is shown in black and JLY-treated cell time course is 
shown in red. Light gray and red shading indicate SEM for control and 
JLY-treated cells, respectively.
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S13). However, after actin dynamics are arrested with JLY, Rac activ-
ity loses its restriction to the morphological leading edge (Figure 6, 
B and C, and Movie S14). The loss of actin dynamics does not extin-
guish Rac activation, but rather causes the Pak-PBD signal to wan-
der throughout the cell. We conclude that actin dynamics are es-
sential for the spatial persistence of Rac activity at the leading edge 
during random migration.
DISCUSSION
Pharmacological inhibitors have been broadly used for studying the 
role of the actin cytoskeleton in a wide array of signaling contexts. 
One of the most commonly used actin drugs is latrunculin, which 
blocks new actin assembly by sequestering the monomeric pool of 
actin (Spector et al., 1983; Coué et al., 1987). Inhibiting new polym-
erization results in the rapid disassembly of the existing cytoskele-
ton, because cells rely on new actin polymerization to balance the 
rapid depolymerization of the existing actin network. Latrunculin-
treated cells have a much smaller pool of polymerized actin than 
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antimycotic (Invitrogen). HL-60 cells were differentiated by adding 
1.5% dimethyl sulfoxide (DMSO; D2650; Sigma-Aldrich, St. Louis, 
MO). HT1080 cells were grown in DMEM (11995, Invitrogen) with 
10% heat-inactivated FBS (Invitrogen) and antibiotic/antimycotic 
(Invitrogen). NIH 3T3 cells were grown in DMEM (11995; Invitrogen) 
with 10% bovine calf serum (BCS; UCSF Cell Culture Facility, San 
Francisco, CA).
Prior to imaging, slides were coated with fibronectin at 0.1 mg/ml 
for 45 min. Then, slides were washed three times with Dulbecco’s 
phosphate-buffered saline. Next slides were blocked with media, 
and HL-60 cells were plated for 15 min at 37°C in complete growth 
media. HT1080 and NIH 3T3 cells were plated for 1 h at 37°C in 
complete growth media. Prior to imaging, slides were washed once 
or twice with media to remove floating cells and debris. NIH 3T3 
cells were imaged in modified Hank’s buffered saline solution 
(mHBSS) with 10% BCS.
Imaging
Images were acquired on a Nikon Ti-E inverted microscope with a 
40× PlanApo 0.95 numerical aperture (NA), 60× Apo TIRF 1.49 NA, 
or 100× Apo TIRF 1.49 NA objective and an electron-multiplying 
Janetopoulos, 2003). If the primary role of actin is to be a passive 
scaffold for signaling components, then JLY-treated cells (which 
maintain the existing organization of the actin cytoskeleton but lose 
actin dynamics) should phenocopy control cells in the dynamics of 
polarity signals. However, JLY-treated cells are unable to maintain 
the spatial persistence of Rac activity at the morphological leading 
edge (Figure 6B), unlike control cells (Figure 6A), which are able to 
do so. These data suggest that actin dynamics, and not only mor-
phological polarity or actin accumulation at the leading edge, are 
required for the proper spatial dynamics of Rac activation in HL-60 
cells. Our combination of actin inhibitors should prove useful in fu-
ture experiments aimed at discriminating the role of actin dynamics 
and global morphological rearrangements for other signals in cell 
polarity and chemotaxis.
MATERIALS AND METHODS
Cell culture
HL-60 cells were cultured as previously described (Weiner et al., 
2007). Briefly, cells were cultured in RPMI 1640 (10-041-CM, Cellgro; 
Mediatech, Manassas, VA) supplemented with 10% heat-inactivated 
fetal bovine serum (FBS; Invitrogen, Carlsbad, CA) and antibiotic/
FIGURE 6: Actin rearrangements are required for the spatial persistence of Rac activity in randomly migrating HL-60 
cells. Rac activity was assayed by TIRF imaging of a fluorescent Rac-GTP–binding domain (Pak-PBD-Cerulean). (A) 
Control cells are polarized and maintain a persistent field of Rac activity at the leading edge. (B) In JLY-treated cells, the 
Rac activity field loses its persistent localization to the leading edge. White dotted line indicates the morphological 
leading edge. Images are representative of a minimum of five cells. Calibration bar indicates intensity (a.u.); scale bar: 
10 μm. (C) Quantification of the spatial persistence of the Rac activity in control and JLY-treated HL-60 cells. Spatial 
persistence is measured by analyzing the vector between the center of mass of the cell and the center of mass of the 
Rac activity field over 11 min, then plotting the angle of those vectors over the fraction of time points in a rose plot.
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charge-coupled device (EM-CCD) camera (Evolve; Photometrics, 
Tucson, AZ) controlled by NIS-Elements (Nikon, Melville, NY). Sam-
ple drift was minimized using an autofocus system (Perfect Focus; 
Nikon). Laser lines (440, 488, 514 nm; all 200 mW) were supplied 
from a Spectral Applied Research LMM5 Laser Merge Module (Rich-
mond Hill, Ontario, Canada). This laser launch uses acousto-optic 
tunable filters (AOTFs) to control laser output to a TIRF fiber for 
imaging or a Mosaic Digital Micromirror device (Andor, Belfast, UK) 
for spatially controlled photobleaching. Bleaching experiments 
were performed with full laser power (488 nm; 200 mW), and TIRF or 
oblique imaging was performed with 50 mW or less (through AOTF 
and neutral density–based laser attenuation).
Calcium assays were imaged using a CCD camera (Cool Snap 
HQ; Photometrics) and a Nikon TE-2000 inverted microscope with a 
20× PlanFluor 0.5 NA objective in an In Vivo Scientific microscope 
incubator (St. Louis, MO) to create a 37°C climate.
NIS-Elements was used for image acquisition, and NIS-Elements, 
ImageJ, MATLAB (MathWorks, Natick, MA), and Microsoft Excel 
(Redmond, WA) were used for data analysis. Pak-PBD images were 
denoised in collaboration with John Sedat (University of  California, 
San Francisco, CA), using software developed by Jerome Boulanger 
(Kervrann and Boulanger, 2006). Default parameters were chosen 
for a two-dimensional time series.
Reagents
The following reagents were used: pig fibronectin (purified in our 
lab from pig plasma), fMLP (F3506; Sigma), cytochalasin D (250255; 
Calbiochem, San Diego, CA), blebbistatin (203389; Calbiochem), 
latrunculin B (428020; Calbiochem), jasplakinolide (420127; Calbio-
chem), Y27632 (688001; Calbiochem), and calcium dye, Fluo-4-AM 
(F14201; Invitrogen).
To test existing methods of arresting actin dynamics, the pub-
lished concentrations of each drug were used (Kueh et al., 2008; 
Renkawitz et al., 2009; Wilson et al., 2010). For cytochalasin D ex-
periments, cells were preincubated with 100 nM fMLP for a mini-
mum of 2 min, and then a solution containing cytochalasin D and 
fMLP was added for a final concentration of 10 μM cytochalasin D 
and 100 nM fMLP. In experiments containing blebbistatin, cells were 
preincubated in 100 nM fMLP and 50 μM blebbistatin for 10 min. 
Cells were then treated with either solutions of latrunculin B or 
jasplakinolide to achieve final concentrations of 100 nM fMLP, 
50 μM blebbistatin, and 500 nM latrunculin B, or 100 nM fMLP, 
50 μM blebbistatin, and 1 μM jasplakinolide, respectively
For JLY treatment, HL-60 cells were preincubated in 100 nM 
fMLP and 10 μM Y27632 for 10 min. Next jasplakinolide and latrun-
culin B were added for a final concentration of 100 nM fMLP, 10 μM 
Y27632, 8 μM jasplakinolide, and 5 μM latrunculin B. In HT1080 
and NIH 3T3 cells, the concentration of Y27632 in the cocktail was 
20 μM Y27632. HT1080 cells were preincubated in 100 nM fMLP 
and 20 μM Y27632 for 10 min, and NIH 3T3 cells were preincubated 
in 20 μM Y27632 for 10 min before the addition of jasplakinolide 
and latrunculin B.
Calcium assay
Cells were incubated for 0.5–1 h at 37°C in media containing 1 μM 
Fluo-4-AM. Next cells were plated as described in the Cell Culture 
section. Neutral density filters were used to attenuate the intensity 
of the fluorescence excitation light to prevent spontaneous release 
of calcium. Cells were loaded and imaged at an intensity signal be-
tween one to two times the background intensity. Positive calcium 
release was scored for cells exhibiting at least a threefold increase in 
fluorescence of intensity. 
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